New concerns about old drugs: Valvular heart disease on ergot derivative dopamine agonists as an exemplary situation of pharmacovigilance

Mov Disord. 2004 Jun;19(6):611-3. doi: 10.1002/mds.20202.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Disclosure*
  • Dopamine Agonists / adverse effects*
  • Ergot Alkaloids / analysis
  • Health Education*
  • Heart Valve Diseases / chemically induced*
  • Humans
  • International Cooperation
  • Pergolide / adverse effects
  • Pergolide / chemistry*
  • Risk Factors

Substances

  • Dopamine Agonists
  • Ergot Alkaloids
  • Pergolide